Vanguard Group
CYRX icon

Vanguard Group’s CryoPort CYRX Stock Holding History

Vanguard Group’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27.9M Buy
2,905,952
+47,921
+2% +$453K ﹤0.01% 2465
2025
Q3 		$27.1M Buy
2,858,031
+69,550
+2% +$585K ﹤0.01% 2473
2025
Q2 		$20.8M Buy
2,788,481
+43,032
+2% +$267K ﹤0.01% 2535
2025
Q1 		$16.7M Buy
2,745,449
+13,245
+0.5% +$91.6K ﹤0.01% 2589
2024
Q4 		$21.3M Sell
2,732,204
-106,699
-4% -$795K ﹤0.01% 2560
2024
Q3 		$23M Buy
2,838,903
+92,622
+3% +$758K ﹤0.01% 2525
2024
Q2 		$19M Sell
2,746,281
-909,044
-25% -$12.2M ﹤0.01% 2605
2024
Q1 		$64.7M Sell
3,655,325
-2,336
-0.1% -$37K ﹤0.01% 2061
2023
Q4 		$56.7M Buy
3,657,661
+98,569
+3% +$1.29M ﹤0.01% 2132
2023
Q3 		$48.8M Buy
3,559,092
+74,037
+2% +$1.09M ﹤0.01% 2150
2023
Q2 		$60.1M Sell
3,485,055
-107,304
-3% -$2.2M ﹤0.01% 2106
2023
Q1 		$86.2M Buy
3,592,359
+57,286
+2% +$1.25M ﹤0.01% 1895
2022
Q4 		$61.3M Buy
3,535,073
+30,459
+0.9% +$642K ﹤0.01% 2073
2022
Q3 		$85.4M Sell
3,504,614
-14,517
-0.4% -$500K ﹤0.01% 1893
2022
Q2 		$109M Buy
3,519,131
+3,826
+0.1% +$102K ﹤0.01% 1762
2022
Q1 		$123M Buy
3,515,305
+159,133
+5% +$6.02M ﹤0.01% 1831
2021
Q4 		$199M Buy
3,356,172
+1,039,468
+45% +$71.9M ﹤0.01% 1610
2021
Q3 		$154M Buy
2,316,704
+24,606
+1% +$1.52M ﹤0.01% 1746
2021
Q2 		$145M Buy
2,292,098
+25,885
+1% +$1.46M ﹤0.01% 1807
2021
Q1 		$118M Buy
2,266,213
+248,033
+12% +$15.1M ﹤0.01% 1866
2020
Q4 		$88.6M Buy
2,018,180
+27,993
+1% +$1.33M ﹤0.01% 1890
2020
Q3 		$94.3M Sell
1,990,187
-43,540
-2% -$1.76M ﹤0.01% 1711
2020
Q2 		$61.5M Buy
2,033,727
+113,315
+6% +$2.52M ﹤0.01% 1900
2020
Q1 		$32.8M Buy
1,920,412
+51,489
+3% +$902K ﹤0.01% 2055
2019
Q4 		$30.8M Buy
1,868,923
+36,438
+2% +$542K ﹤0.01% 2330
2019
Q3 		$30M Buy
1,832,485
+127,865
+8% +$2.56M ﹤0.01% 2292
2019
Q2 		$31.2M Buy
1,704,620
+203,846
+14% +$3.23M ﹤0.01% 2325
2019
Q1 		$19.4M Buy
1,500,774
+107,034
+8% +$1.16M ﹤0.01% 2522
2018
Q4 		$15.4M Buy
1,393,740
+126,433
+10% +$1.37M ﹤0.01% 2564
2018
Q3 		$16.2M Sell
1,267,307
-31,071
-2% -$443K ﹤0.01% 2683
2018
Q2 		$20.5M Buy
1,298,378
+163,521
+14% +$1.74M ﹤0.01% 2554
2018
Q1 		$9.76M Sell
1,134,857
-10,661
-0.9% -$94.2K ﹤0.01% 2836
2017
Q4 		$9.84M Buy
1,145,518
+173,600
+18% +$1.36M ﹤0.01% 2828
2017
Q3 		$9.57M Buy
971,918
+452,818
+87% +$3.33M ﹤0.01% 2829
2017
Q2 		$2.55M Buy
519,100
+255,519
+97% +$834K ﹤0.01% 3311
2017
Q1 		$622K Buy
263,581
+96,700
+58% +$318K ﹤0.01% 3707
2016
Q4 		$541K Buy
166,881
+123,868
+288% +$301K ﹤0.01% 3717
2016
Q3 		$85K Buy
43,013
+12,900
+43% +$25.4K ﹤0.01% 3997
2016
Q2 		$63K Buy
30,113
+5,700
+23% +$11.4K ﹤0.01% 4062
2016
Q1 		$52K Buy
24,413
+800
+3% +$1.41K ﹤0.01% 4073
2015
Q4 		$48K Hold
23,613
– – ﹤0.01% 4137
2015
Q3 		$56K Buy
+23,613
New +$66.8K ﹤0.01% 4134

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group's CYRX Position: Q4 2025 in Review

Vanguard Group increased its CryoPort (CYRX) stake by 1.7% in Q4 2025, buying an estimated $453K and bringing the position to 2,905,952 shares worth $27.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

Vanguard Group first reported a position in CYRX in Q3 2015 and has held it in 42 quarters since. The position peaked at $199M in Q4 2021. 172 funds tracked by Wall St. Rank hold CYRX as of Q4 2025.

  • Vanguard Group held 2,905,952 shares of CryoPort worth $27.9M as of Q4 2025.
  • Vanguard Group bought 47,921 CryoPort shares in Q4 2025, an estimated $453K.
  • CryoPort made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2465 holding.
  • Vanguard Group first reported a position in CryoPort in Q3 2015 and has held it in 42 quarters since.
  • Vanguard Group's CryoPort position peaked at $199M in Q4 2021.
  • 172 funds tracked by Wall St. Rank held CryoPort as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.